NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 908 filers reported holding NOVARTIS A G in Q1 2017. The put-call ratio across all filers is 2.34 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $5,699,000 | -5.6% | 76,734 | -7.4% | 0.07% | -9.1% |
Q4 2016 | $6,038,000 | -12.1% | 82,897 | -4.7% | 0.08% | -18.9% |
Q3 2016 | $6,867,000 | -0.9% | 86,970 | +3.6% | 0.10% | -9.5% |
Q2 2016 | $6,927,000 | +13.9% | 83,949 | +0.0% | 0.10% | +15.4% |
Q1 2016 | $6,080,000 | -39.0% | 83,931 | -27.5% | 0.09% | -37.2% |
Q4 2015 | $9,964,000 | +37.9% | 115,805 | -0.0% | 0.14% | +39.4% |
Q3 2015 | $7,223,000 | -43.8% | 115,830 | -11.3% | 0.10% | -29.3% |
Q2 2015 | $12,846,000 | -17.4% | 130,627 | -17.2% | 0.15% | -5.8% |
Q1 2015 | $15,555,000 | -20.6% | 157,740 | -25.4% | 0.16% | -15.2% |
Q4 2014 | $19,584,000 | -2.6% | 211,351 | -1.1% | 0.18% | 0.0% |
Q3 2014 | $20,111,000 | -6.2% | 213,654 | -9.8% | 0.18% | +5.7% |
Q2 2014 | $21,443,000 | -6.5% | 236,862 | -12.2% | 0.17% | -1.1% |
Q1 2014 | $22,944,000 | +1.7% | 269,861 | -3.8% | 0.18% | +12.8% |
Q4 2013 | $22,551,000 | +10.7% | 280,556 | +5.7% | 0.16% | +11.4% |
Q3 2013 | $20,370,000 | -2.4% | 265,540 | -10.1% | 0.14% | -0.7% |
Q2 2013 | $20,880,000 | – | 295,290 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
PRENTISS SMITH & CO INC | 127,510 | $11,721,000 | 6.50% |
MANAGED ASSET PORTFOLIOS, LLC | 127,716 | $11,740,000 | 6.04% |
EXENCIAL WEALTH ADVISORS, LLC | 116,917 | $10,747,000 | 5.25% |
MCDANIEL TERRY & CO | 181,095 | $16,646,000 | 4.64% |
Fayerweather Charles | 18,180 | $1,671,000 | 4.54% |
Osher Van de Voorde Investment Management | 78,138 | $7,182,000 | 4.38% |
BROWN BROTHERS HARRIMAN & CO | 9,291,495 | $854,074,000 | 4.35% |
Boulegeris Investments, Inc. | 61,322 | $5,637,000 | 4.31% |
DODGE & COX | 45,723,035 | $4,202,861,000 | 4.23% |
WHV Investments, Inc. | 1,603,476 | $152,945,000 | 4.23% |